Interferon-treated cultures of Ly cells survived initial infection with high multiplicities of vesicular stomatitis (VSV) or herpes simplex virus (HSV). In the case of HSV, infectious virus and intracellular viral antigen were rapidly eliminated from the interferon-treated cultures, and the cells grew out to form apparently normal monolayers that could be cultured indefinitely. In the VSVinfected L. cultures, virus titers remained at low levels in interferon-treated cells but after about 14 days rapidly rose and the culture was destroyed. If interferon was added to the medium on days 4 and 6 after infection, virus titers rapidly declined but again recovered and the cells were destroyed. If, however, interferon treatment was resumed 9 days after initial infection, detectable infectious VSV was eliminated from the medium. Several methods, including cocultivation and molecular hybridization, failed to demonstrate persistence of a significant portion of the VSV genome in these cultures.
In many reported studies, interferon treatment has not prevented the destruction of virus-infected cells (12) . Because of this, the protective effect of interferon on tissues or whole animals is usually thought to be due to reduced virus yields from interferon-treated and then virus-infected cells, which may often themselves be destroyed by the infection. However, with high concentrations of interferon in sensitive L cells infected with mengovirus, which is only moderately sensitive to interferon, cytopathic effects (CPEs) did develop late in infection (6) .
During the course of interferon assays employing a very interferon-sensitive cell system (L. cells) and virus (vesicular Fluorescent-antibody studies. Infected and uninfected monolayer cultures were gently trypsinized, and cell smears were prepared in Teflon-coated well-slides. Air-dried smears were immediately fixed in cold acetone for 10 min, allowed to dry, and reacted for 30 min at 37 C with a drop of a 1:20 dilution of a human serum with a known fluorescent antibody titer to an HSV late antigen of 1:1,280. After 30 min of incubation, the slides were washed three times in phosphate-buffered saline, and the cells were stained with a 1:10 dilution of fluoresceinated goat anti-human gamma globulin (Hyland) for 30 min at 37 C. At the end of the incubation period, the slides were again washed three times in phosphate-buffered saline, mounted in a 50% glycerine solution, and examined under ultraviolet light with a Zeiss Universal fluorescence microscope (exciting filter no. BG-12; barrier filter no. 53).
RESULTS
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were infected at various multiplicities of VSV ranging from 10 to 100 TCID5() per cell. The results shown in Fig. 1 , 2, and 4 were determined from cultures infected at a multiplicity of 50 to 100, but similar results were obtained in experiments at lower multllicities of infection.
If cells were treated with l1i U of interferon per ml only on the day before infection, some CPE of the infection was noted on subsequent days, but it was by no means complete. Detached cells could be seen in the medium, and growth to confluent monolayers was slow. The cells could, however, be treated with trypsin and split at a 1:5 dilution on day 4 after infection. Titers of virus in the interferon-treated cultures appeared to be reduced by only 2 log,( as compared with untreated, control cultures ( Fig. 1) , in which all cells were killed by 10 h after infection. This was probably not an accurate estimate of the extent of the antiviral effect of the interferon treatment because of the high titer of unabsorbed virus at the large multiplicity of virus employed.
After day 1 of infection, virus titers in the Fig. 1) . They remained at about this level for 5 days, whereupon the titers of virus rapidly rose again, reaching 105 5 TCID5,, by day 14. At this point, all of the cells in the culture showed a viral CPE, and the experiment was terminated. It should be noted that throughout the course of this experiment the cultures were never entirely free from CPE, and minimal cell damage was observed with rounded cells that had been released from the monolayer present in the culture fluids.
The observations on the experiment summarized in Fig. 1 were extended to other cell cultures in which interferon was added to the medium at various times after VSV infection. In Fig. 2 one experiment is summarized in which interferon (100 U/ml) was added to the culture medium at the time of medium change on days 4 and 6 of the experiment. This experiment and the one summarized in Fig. 4 were run simultaneously on the same cell lot under conditions similar to those used in Fig. 1 . In the experiment summarized in Fig. 2 , a decrease in virus titer was noted subsequent to the addition of interferon to the medium at days 4 and 6 and, instead of leveling at about 103 TCID,, as in the previously discussed experiment (Fig. 1) , the titer of virus in the medium dropped to an undetectable concentration (<10 TCID.,Jdml) by day 12. Subsequently, the titer rose to almost 107 log10 TCID,o by day 18. The monolayer was completely destroyed at that point. In summary, comparing Fig. 2 with Fig. 1 , addition of interferon to the cell cultures at 4 and 6 days after infection caused an immediate decrease in virus production and delayed the appearance of complete CPE by 4 days. As in the case of the cultures discussed in Fig. 1 , those in Fig. 2 showed a moderate degree of CPE until days 10 and 11. At day 12, when the titer was less than 10' TCIDso, the cells appeared to be completely normal. By day 15, however, obvious CPE reappeared, becoming progressively worse until the culture was completely destroyed on day 18.
One point of interest was the rapid decrease in virus titer after the addition of interferon on days 4 and 6. This was actually more rapid than was observed in a straightforward heat inactivation of VSV at 37 C (Fig. 3) . The rapid decline of virus titers and prolonged survival of the cell cultures depicted in Fig. 2 Fig. 4 , where interferon was added to the cultures on days 9, 11, and 15. In this experiment a rapid decrease in virus titer was again noted after addition of interferon. By day 12, the titer had decreased to less than 10 TCID.,dml; however, in this experiment the titers, with one exception, remained at this level. After day 15, virus was never again recovered from the cultures despite numerous VOL. 13, 1976 Effect of interferon treatment on HSV infection. Conditions similar to those employed in experiments with VSV were used in HSV studies, except that the multiplicity of infection was 10 and the interferon concentration employed was 1,000 U/ml. The former was necessary because significantly higher multiplicities of virus completely destroyed the Ly cultures under all conditions studied. The higher concentration of interferon regularly inhibited viral CPE, although in some studies 100 or 300 U sufficed to do so. Persistent infection in L cells with HSV has been reported previously (7) .
In cells treated with 1,000 U of interferon per ml and then infected with HSV at a multiplicity of 10, about 40% of the monolayer was severely damaged by the virus after 18 to 24 h of infection; in contrast, virus controls not treated with interferon showed even more complete cytopathology after 8 h of infection, and by 18 to 24 h only a small number of rounded-up cells remained attached to the substratum. In the interferon-treated cultures, slow cell growth started 2 to 3 days after infection, and by day 4 a sufficient number of cells was present to split the monolayer after trypsin treatment. In this experiment titers of HSV were reduced by 103-fold in interferon-treated cultures after 24 h (Fig. 5) . A steady decline in virus titers in the culture fluids was noted over the next few days until by day 5 less than 10 TCIDj,,/ml could be found; no virus was detected in subsequent assays of the culture flu- "To 1 ml of Ly or Ly or LYVvs) DNA, (1 mg/ml), containing 1.5 ng of 3H-labeled VSV RNA (2 x 10" counts/min per Ag) was added. The mixtures were incubated in 2x SSC at 66 to 68 C. Aliquots were removed at 0, 24, and 72 h and assayed for acidprecipitable radioactivity before and after RNase treatment. The results are presented as the percentage of acid-precipitable counts that remained acid precipitable after RNase treatment. ids. No additional interferon treatment was necessary under these conditions.
In this experiment, HSV-infected and interferon-treated cells were tested for HSV antigens by an immunofluorescence assay (Table  2 ). In the virus-infected controls, almost all of the cells were positive for HSV antigens after 8 and 24 h of infection; in the interferon-treated group 82% were positive at 8 h and 44% were positive at 24 h. Subsequently, no HSV antigen could be demonstrated in these cultures. In the cells that were positive, there was no obvious difference in the intensity of fluorescence between the interferon-treated and control cells.
One point of interest was that the decrease in HSV titers in the culture fluids in the experiment summarized in Fig. 5 was more rapid than the decline noted in HSV titers by heat inactivation at 37 C (Fig. 6) . DISCUSSION Our results are of interest for two main reasons. First, they indicate that in interferonpretreated cells a chronic infection may be set up by viruses that are ordinarily rapidly cytopathic. If further interferon treatment is instituted at the proper interval, the culture may be "cured" of its chronic infection, with no evidence found by us for persistence of the viral genome. This means that interferon-treated cells, under some conditions, can recover fully from a virus infection. It also suggests that recurrent alternating cycles of virus and subsequent interferon production or interferon treatment might be responsible for maintaining a VOL. 13, 1976 on November 2, 2017 by guest http://iai.asm.org/ Downloaded from chronic virus infection. Although such a situation was not seen in these studies, previous reports of tissue culture systems have suggested that it is indeed possible (5).
One interesting observation was the rapidity of the decline in virus titers in the interferontreated cultures. In the cases of both VSV and HSV, the decline was more rapid than was seen with simple heat inactivation at 37 C. This suggests that more than heat inactivation was at work and that interferon-treated cells may act as traps for infecting viruses (1) . A virus can adsorb to and enter an interferon-treated cell; normal uncoating follows, but at that point, or soon after, the replication process is interrupted (12) . The viral genome may have been destroyed by nucleolytic enzymes after a period of time if its replication process is thus inhibited.
Second, these studies may be of importance because interferon treatments appeared to bring about a complete recovery of the virusinfected L, cells. No evidence for persistence of a sizable segment of the virus genome could be uncovered. This is of interest in the light of a recently published study on cells infected with a temperature-sensitive mutant of respiratory syncytial virus. In this study, infectious proviral DNA was found by transfection with DNA from cells that had been infected by a temperature-sensitive mutant of respiratory syncytial virus and carried at a nonpermissive temperature (11) . Similar results were reported with WSN influenza virus in the same paper. In addition, cells chronically infected with tickborne encephalitis virus, an arbovirus, or with measles virus have recently been reported, in a molecular hybridization study (15, 16) , to have virus-specific DNA sequences. A recent report indicated that proviral DNA may also be produced by a VSV mutant (M. Moreau, B. Sanchez, and C. Chaney, manuscript in preparation). These reports together suggest that all modalities of antiviral therapy should be checked to determine whether they also facilitate the introduction of viral genetic information into the genome of host cells. The results of the present study suggest, however, that proviral DNA is not necessarily integrated into the genome of interferon-treated cells. This is consistent with the finding that interferon actually inhibits transformation by simian virus 40, a process that requires integration of viral DNA into the host genome (14) . However, the question of the persistence of viral genetic information in the genome of host cells infected with viral mutants or treated with antiviral substances, including interferon, before or during infection, is one that obviously must be pursued further.
Finally, it is of interest to compare the effect of interferon indicated here with those previously reported systems in which a virus genome was already integrated into the DNA of the host before institution of interferon treatment. In the case of simian virus 40-transformed cells, prolonged treatment with interferon had no effect on the production of T antigen (9) . In AKR cells which chronically produced murine leukemia virus, virus production was inhibited as long as interferon was present in the medium, but virus titers returned to control levels when interferon was removed (4). The evidence indicates that interferon may inhibit integration of viral DNA into the genome of the host cell but that it does not appear to affect viral DNA already integrated.
